Market revenue in 2022 | USD 1,057.9 million |
Market revenue in 2030 | USD 774.3 million |
Growth rate | -3.8% (CAGR from 2022 to 2030) |
Largest segment | Nasopharyngeal (np) swab |
Fastest growing segment | Oropharyngeal (OP) swab |
Historical data covered | 2020 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nasopharyngeal (NP) swab, Oropharyngeal (OP) swab, Nasal Swabs, Saliva |
Key market players worldwide | Abbott Laboratories, Mylab Discovery Solutions, Converge Technology Solutions Corp, Thermo Fisher Scientific Inc, Roche, Danaher Corp, Birks Group Inc Class A, Cue Health Inc, Quest Diagnostics Inc, SD Biosensor |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 detection poc kits market will help companies and investors design strategic landscapes.
Nasopharyngeal (np) swab was the largest segment with a revenue share of 58% in 2022. Horizon Databook has segmented the Asia Pacific covid-19 detection poc kits market based on nasopharyngeal (np) swab, oropharyngeal (op) swab, nasal swabs, saliva covering the revenue growth of each sub-segment from 2020 to 2030.
The increasing pool of local diagnostic kits & reagents manufacturers providing testing solutions for COVID-19 detection contributed to revenue generation in the region. Furthermore, collaborations between countries are expected to boost the adoption of COVID-19 diagnostic products in the region.
In addition, several local companies have entered into partnerships with international companies for developing and manufacturing COVID-19 diagnostic tests. In May 2020, Duke-NUS Medical School from Singapore collaborated with Diagnostics Development Hub & Gen Script Biotech for developing & manufacturing a COVID-19 detection system.
In March 2020, Osaka-based Kurabo Industries launched a 15-minute testing kit to be marketed in Japan. In April 2020, Toyobo Co., a Japanese biotechnology company, developed a COVID-19 testing kit that can generate results within an hour. Similarly, in May 2020, Japanese authorities approved Fuji Rebio, Inc.'s SARS COV-2 antigen test kit.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific covid-19 detection poc kits market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific covid-19 detection poc kits market from 2020 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account